Arthritis Trial Finder

14022 ATTUNE Cementless RP Clinical Performance Evaluation

Study Purpose

The primary objective of this study is to examine the change from pre-operative baseline to two year postoperative functional performance improvement for the ATTUNE primary, cementless TKA RP system as measured with the KOOS questionnaire (KOOS-ADL sub-score). This will be carried out for two configurations: cruciate retaining rotating platform (ATTUNE Cementless CR RP) and posterior stabilized rotating platform (ATTUNE Cementless PS RP).

Recruitment Criteria

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

Accepts Healthy Volunteers
No

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Study Type
Interventional
Eligible Ages 22 Years - 80 Years
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Subject is male or female and between the ages of 22 and 80 years at the time of surgery, inclusive.
  • - Subject was diagnosed with NIDJD.
  • - Subject, in the opinion of the Investigator, is a suitable candidate for cementless primary TKA using the devices described in this CIP with either resurfaced or non-resurfaced patellae.
  • - Subject that is willing to give voluntary, written informed consent to participate in this clinical investigation and authorize the transfer of his/her information to the Sponsor - Subject is currently not bedridden - Subject, in the opinion of the Investigator, is able to understand this clinical investigation and is willing and able to perform all study procedures and follow-up visits and co-operate with investigational procedures.
  • - Subject is able to read, and comprehend the Informed Consent Document as well as complete the required PROs in either English or one of the available translations.

Exclusion Criteria:

  • - The Subject is a woman who is pregnant or lactating.
  • - Contralateral knee has already been enrolled in this study .
  • - Subject had a contralateral amputation.
  • - Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy or primary TKA in affected knee.
  • - Subject is currently diagnosed with radicular pain from the spine that radiates into the limb to receive TKA.
  • - Subject has participated in a clinical investigation with an investigational product (drug or device) in the last three (3) months.
  • - Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
  • - Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in the last 5 years) or has a psychological disorder that could affect their ability to complete patient reported questionnaires or be compliant with follow-up requirements.
  • - Subject was diagnosed and is taking prescription medications to treat a muscular disorder that limits mobility due to severe stiffness and pain such as fibromyalgia or polymyalgia.
  • - Subject has a significant neurological or musculoskeletal disorder(s) or disease that may adversely affect gait or weight bearing (e.g., muscular dystrophy, multiple sclerosis, Charcot disease).
  • - Subject is suffering from inflammatory arthritis (e.g., rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, etc.).
  • - Subject has a medical condition with less than five (5) years life expectancy.
- Uncontrolled gout

Trial Details

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

Trial ID:
NCT02839850

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Phase
N/A

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Lead Sponsor
DePuy Orthopaedics

The person who is responsible for the scientific and technical direction of the entire clinical study.

Principal Investigator
Sue Kemp, B.Sc., Ph.D.
Principal Investigator Affiliation Sponsor GmbH

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Agency Class
Industry
Overall Status Recruiting
Countries Austria, Canada, France, Germany, Netherlands, New Zealand, United Kingdom, United States

The disease, disorder, syndrome, illness, or injury that is being studied.

Conditions
Osteoarthritis
Additional Details

The secondary objectives of this study are:

  • - Evaluate change from preoperative baseline in post-operative outcomes using additional patient reported measures at 2 years: PKIP (overall and sub-scores), KOOS (overall and sub-scores), AKS and EQ-5D-3L.
  • - Evaluate change from preoperative baseline in pain and satisfaction over time as measured using a modified VAS Pain Score (discrete numbers rather than a continual scale) at 2yr.
  • - Evaluate type and frequency of Adverse Events - Evaluate survivorship of the ATTUNE Primary Cementless TKA system for the CR RP and PS RP configurations using Kaplan-Meier survival analysis at 2yr and 5yrs.
  • - Evaluate primary, cementless ATTUNE TKA fixation through zonal radiographic analysis of the bone-implant interface at 6wk, 6mo, 1yr, and 2yr after surgery.
  • - Evaluate any changes in anatomic tibiofemoral, femoral component and tibial component alignment at 2 years compared to the first postoperative radiographs.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Newport News, Virginia

Status

Recruiting

Address

Newport News, Virginia,

Lubbock, Texas

Status

Recruiting

Address

Lubbock, Texas,

New London, New Hampshire

Status

Recruiting

Address

New London, New Hampshire,

DeLand, Florida

Status

Recruiting

Address

DeLand, Florida,

International Sites

Wrightington Hospital, Wigan, United Kingdom

Status

Recruiting

Address

Wrightington Hospital

Wigan, ,

Christchurch, New Zealand

Status

Active, not recruiting

Address

Christchurch, ,

Helmond, Netherlands

Status

Recruiting

Address

Helmond, ,

Garmisch-Partenkirchen, Germany

Status

Active, not recruiting

Address

Garmisch-Partenkirchen, ,

CHU de la Cavale Blanche, Brest, Cedex, France

Status

Recruiting

Address

CHU de la Cavale Blanche

Brest, Cedex, 29285

Site Contact

Frederic Dubrana

Frederic.dubrana@chu-brest.fr

+33607597865

Calgary, Alberta, Canada

Status

Recruiting

Address

Foothills Medical Centre, University of Calgary

Calgary, Alberta,

Site Contact

Shannon Puloski

spuloski@ucalgary.ca

403-944-8635

Ried im Innkreis, Upper Austria, Austria

Status

Recruiting

Address

Krankenhaus der Barmherzigen Schwestern Ried im Innkreis

Ried im Innkreis, Upper Austria, 4910

Site Contact

Norbert Freund

ortho.ried@bhs.at

+437752602

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation.

Getting involved in science in one form or another allows you and your loved ones to help scientists find better treatments for others in the future. Clinical trials and disease registries are part of clinical research and are at the heart scientific discovery.

You have the power to influence the research conducted by scientists in other way too, like taking surveys or serving on committees. Below are current opportunities: